Published in J Hepatol on January 26, 2007
Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples. Clin Gastroenterol Hepatol (2010) 0.90
Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients. Hepat Mon (2011) 0.85
Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis (2008) 0.83
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
The glutathione biosynthetic pathway of Plasmodium is essential for mosquito transmission. PLoS Pathog (2009) 1.28
Opportunities to use drugs and stages of drug involvement outside the United States: Evidence from the Republic of Chile. Drug Alcohol Depend (2009) 1.13
Parental monitoring at age 11 and smoking initiation up to age 17 among Blacks and Whites: a prospective investigation. Nicotine Tob Res (2009) 0.96
Self-reported physical activity in Hispanic adults living with HIV: comparison with accelerometer and pedometer. J Assoc Nurses AIDS Care (2008) 0.93
Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis. Ann Hepatol (2008) 0.88
Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender. J Clin Gastroenterol (2006) 0.86
Student performance on smoking cessation counseling with standardized patients. Fam Med (2011) 0.84
Characteristics of inmates witnessing overdose events in prison: implications for prevention in the correctional setting. Harm Reduct J (2009) 0.84
Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy. J Clin Virol (2006) 0.82
Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks. J Med Virol (2008) 0.82
Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients. Dig Dis Sci (2006) 0.79
Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C. P R Health Sci J (2004) 0.79
Clinical challenges and controversies in the management of HIV/ HCV-coinfected individuals. P R Health Sci J (2004) 0.78
Behavioral problems and the occurrence of tobacco, cannabis, and coca paste smoking in Chile: evidence based on multivariate response models for school survey data. Drug Alcohol Depend (2009) 0.77
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin. Dig Dis Sci (2005) 0.77
Incidence of Multiple Sclerosis in Puerto Rico, 2014: A Population-Based Study. Neuroepidemiology (2017) 0.75
Rapid quantification of resveratrol in mouse plasma by ultra high pressure liquid chromatography (UPLC) coupled to tandem mass spectrometry. P R Health Sci J (2014) 0.75
Evolution of faculty affairs and faculty development offices in U.S. medical schools: a 10-year follow-up survey. Acad Med (2013) 0.75